All Updates

All Updates

icon
Filter
Funding
Taysha Gene Therapies to raise USD 75 million in underwritten public offering
Cell & Gene Therapy
Jun 25, 2024
This week:
Funding
​​OpenAI secures USD 4 billion revolving line of credit
Generative AI Applications
Yesterday
Product updates
Oracle adds GenAI capabilities to HeatWave to improve performance of transactional applications
Generative AI Infrastructure
Yesterday
Product updates
Cohere updates fine-tuning service for AI language models and enhances offering
Generative AI Infrastructure
Yesterday
Product updates
Dataiku launches LLM Guard Services to manage enterprise GenAI deployments
Generative AI Infrastructure
Yesterday
Product updates
Black Forest Labs launches Flux 1.1 Pro and new API
Foundation Models
Yesterday
Product updates
Cohere updates fine-tuning service for AI language models
Foundation Models
Yesterday
Product updates
Appy Pie launches AI model 'Flawless Text' for image generation
Foundation Models
Yesterday
Product updates
Appy Pie launches AI model 'Flawless Text' for image generation
No-code Software
Yesterday
Partnerships
Terra Quantum partners with RWTH Aachen University to enhance molecular conformer search in drug discovery
Quantum Computing
Yesterday
Product updates
GenoPalate launches upgraded Food Index Report for personalized nutritional guidance
Functional Nutrition
Yesterday
Cell & Gene Therapy

Cell & Gene Therapy

Jun 25, 2024

Taysha Gene Therapies to raise USD 75 million in underwritten public offering

Funding

  • Texas-based gene therapy company Taysha Gene Therapies has announced an underwritten public offering of up to USD 75 million of common stock and pre-funded warrants. The company also granted underwriters a 30-day option to purchase 15% of the common shares.

  • The funds from the offering are intended to support the company's operations and development programs, though specific details were not provided. Other details, such as the size, closing date, and terms of the offering, were not disclosed.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.